Pharmacy Coverage

Omnipod® is available through the pharmacy.

The Omnipod® 5 Automated Insulin Delivery System and the Omnipod DASH® Insulin Management System are available nationwide through retail, mail-order and specialty pharmacies, including major retailers like Walmart, Walgreens, CVS, Amazon, as well as cash pay.

Most Omnipod DASH® and Omnipod® 5 users pay less than $50/mo. through the pharmacy.​

Omnipod DASH average calculation based on a consumption of ten (10) Pods per month.  Majority defined as at least 70% of patient co-pays under $50 per month. 276,024 paid claims between January 1st, 2021 and December 31st, 2021, both for commercial plans and Medicare, were analyzed. Actual co-pay amount depends on patient’s health plan and coverage, they may fluctuate and be higher or lower than the advertised amount on a monthly basis. Source: Data on file.
Omnipod 5 calculation is based on a consumption of ten (10) Pods per month.  Majority defined as at least 70% of patient co-pays $50 or less per month . Among All Paid Omnipod 5 G6 Pods Commercial and Medicare Claims from August 2022 through July 2023. Includes benefits and offerings available through Insulet, such as the copay card program. Actual co-pay amount depends on patient’s health plan and coverage, they may fluctuate and be higher or lower than the advertised amount on a monthly basis.  Source: IQVIA OPC Library

Get Started on Omnipod through the Pharmacy:

ASPN Pharmacies and its dedicated staff power the Omnipod Pharmacy Support Program. The ASPN team is here for you to check your coverage and help coordinate fulfillment at your pharmacy of choice.

  1. Complete this form* to have the Omnipod Pharmacy Support Program Team facilitate your prescription process. Or, have your healthcare provider send your Omnipod prescription† directly to ASPN Pharmacies LLC.
  2. A dedicated Omnipod Pharmacy Support Program team member will reach out by text or phone call in an average of 3-5 business days. They will also text you periodically to keep you updated on your prescription status.
  3. Once they have your prescription, they'll check your pharmacy coverage for Omnipod®, your free-trial eligibility and future co-pay costs. Results are reported back within an average of 3-5 business days, after hearing back from your doctor.

*This form allows our team members to contact your doctor for an Omnipod prescription and check your insurance coverage.

†When requesting the Omnipod® 5 System prescription, please have your healthcare provider send prescriptions for both the Omnipod 5 G6 Intro Kit (Gen 5/NDC: 08508-3000-01) and the Omnipod 5 G6 Pods (Gen 5/NDC: 08508-3000-21) to ASPN Pharmacies LLC. Please note that a separate prescription is required for the Dexcom G6 system, which is required to use Omnipod 5 in Automated Mode.

Pharmacy Advantage with the OmnipodPromise

We know flexibility is important, especially when it comes to managing diabetes. That's why we're proud to offer our OmnipodPromise™, which may allow you to start on Omnipod without committing to the 4-year DME lock-in period that comes with most traditional insulin pumps. Omnipod can often be accessed through your pharmacy benefits, which means you’ll be able to easily upgrade to new Omnipod technology when available and covered by your insurance.*

Tied to a 4-year DME lock-in period?

No problem. Getting Omnipod supplies at the pharmacy means you may be able to start Pod therapy regardless of an existing durable medical equipment lock-in period.

*Only available for users with valid prescription and coverage through their pharmacy benefit. Upgrades subject to user’s insurance coverage.

Risk Statement
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®. 

The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The  Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value. 
 

WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population. 

The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.


WARNING: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

The Omnipod DASH® Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin. Additionally, the Omnipod DASH® System is interoperable with a compatible blood glucose meter to receive and display blood glucose measurements. The Omnipod DASH® System has been tested and found to be safe for use with the following U-100 insulin: NovoLog®, Humalog®, Apidra®, Fiasp®, Lyumjev®, or Admelog®. Refer to the Omnipod DASH® Insulin Management System User Guide at omnipod.com for complete safety information including indications, contraindications, warnings, cautions, and instructions.